ROLE OF GRB2-ASSOCIATED BINDER 1 (GAB1) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-INDUCED SIGNALING IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

od Hoeben, A., Martin, D., Clement, P. M., Cools, J., Gutkind, J. S.
Izdano 2012

Generation of the Fip1l1–Pdgfra fusion gene using CRISPR/Cas genome editing

od Vanden Bempt, M, Demeyer, S, Mentens, N, Geerdens, E, De Bock, C E, Wlodarska, I, Cools, J
Izdano u Leukemia (2016)

Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system

od Bornschein, S, Demeyer, S, Stirparo, R, Gielen, O, Vicente, C, Geerdens, E, Ghesquière, B, Aerts, S, Cools, J, de Bock, C E
Izdano u Leukemia (2018)

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

od Degryse, S, de Bock, C E, Demeyer, S, Govaerts, I, Bornschein, S, Verbeke, D, Jacobs, K, Binos, S, Skerrett-Byrne, D A, Murray, H C, Verrills, N M, Van Vlierberghe, P, Cools, J, Dun, M D
Izdano u Leukemia (2018)

Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

od Degryse, S., de Bock, C. E., Demeyer, S., Govaerts, I., Bornschein, S., Verbeke, D., Jacobs, K., Binos, S., Skerrett-Byrne, D. A., Murray, H. C., Verrills, N. M., Van Vlierberghe, P., Cools, J., Dun, M. D.
Izdano u Leukemia (2018)